Graftys

Graftys is a medical technology company based in Aix-en-Provence, France, founded in 2005. The company specializes in the development, manufacturing, and commercialization of synthetic bioactive orthopedic biomaterials, particularly calcium phosphate-based bone graft substitutes. Graftys operates internationally, with product registrations in over 30 countries, including Europe, the USA, and South America. The product portfolio includes synthetic and bioresorbable bone graft substitutes and bone cements for various applications in bone reconstructive and trauma surgery, fracture repair, and dental surgery. Notable products are Graftys QuickSet, a calcium phosphate cement designed for injectable use, and Graftys HBS, an injectable bone graft substitute. Graftys emphasizes clinical evidence and innovation, maintaining a strong research and development pipeline in collaboration with leading academic institutions to address unmet medical needs in orthobiologics. Their products are designed to be sterile, have a four-year shelf life, and facilitate ease of use in surgical procedures.

• Employees 9
• Founded 2005
• Annual Revenue $5000000
• Total Funding $12413415